Target intelligence / Profile preview

Protein unc-93 homolog B1 (UNC93B1)

Target
UNC93B1
Molecular classification
Other (12-pass transmembrane trafficking chaperone)
01

Overview

Protein unc-93 homolog B1 (UNC93B1) is a polytopic transmembrane protein that acts as a critical trafficking chaperone for nucleic acid–sensing toll-like receptors (TLRs), specifically TLR3, TLR7, TLR8, TLR9, TLR11, TLR12, TLR13, and also TLR5. UNC93B1 is required for the correct trafficking of these TLRs from the endoplasmic reticulum to their respective signaling compartments (endosomes or plasma membrane), enabling proper recognition of pathogen-associated molecular patterns and appropriate innate immune responses. Deficiency or mutation in UNC93B1 disrupts TLR trafficking and signaling, predisposing individuals to severe infections (notably HSV-1 encephalitis) and, in some cases, autoimmune or autoinflammatory disease. UNC93B1 acts not as a direct receptor or enzyme but as an accessory/trafficking protein essential for TLR function and immune defense regulation[1][2][3][4].

Other names
Unc-93 homolog B1UNC93UNC93BUnc-93B1hUNC93B1IIAE1TLR signaling regulatorunc-93 related proteinunc93 homolog B1
02

Biological functions

Immune responseSignal transductionRegulation of toll-like receptor traffickingProtein stabilization
03

Disease associations

Infection (especially susceptibility to Herpes simplex virus type 1 encephalitis)Autoimmunity/autoinflammatory diseaseInflammation
04

Safety considerations

Loss or mutation can lead to severe viral infections (e.g., HSV-1 encephalitis)[1]Mutations may provoke autoinflammatory disorders due to dysregulated TLR signaling[1]
05

Biomarkers

Susceptibility to HSV-1 encephalitis (loss-of-function mutations used diagnostically)

Beyond the preview

Go deeper on Protein unc-93 homolog B1 (UNC93B1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein unc-93 homolog B1 (UNC93B1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call